Cancer immune monitoring center
Cancer Immune Monitoring and Analysis Center
This program runs standardized immune tests on cancer patients' blood and tumor samples to help doctors understand who benefits from immunotherapy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11109432 on NIH RePORTER |
What this research studies
This center performs a common set of laboratory tests on blood and tumor samples from people in cancer immunotherapy trials so results can be compared across studies. The team harmonizes assays across multiple institutions and offers some specialized tests that collaborating sites can access. Results and standardized data are pooled to look for biomarkers linked to treatment response, resistance, and immune-related side effects. The work supports many phase I/II immunotherapy trials by analyzing patients' biospecimens rather than testing a specific drug.
Who could benefit from this research
Good fit: Patients with cancer who are enrolled in partner immunotherapy clinical trials or who can donate blood or tumor samples for analysis are the ideal candidates.
Not a fit: People without cancer or those not enrolled in a collaborating trial or not providing samples are unlikely to receive direct benefit from this program.
Why it matters
Potential benefit: If successful, the program could help predict who will respond to immunotherapy, spot early signs of resistance, and reduce harmful side effects by guiding treatment choices.
How similar studies have performed: Related immune-monitoring efforts have identified biomarkers linked to responses in some cancers, but reliably predicting benefit across many patients remains a work in progress.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Wu, Catherine Ju-Ying — Dana-Farber Cancer Inst
- Study coordinator: Wu, Catherine Ju-Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.